Literature DB >> 21148035

Neonatal FcR overexpression boosts humoral immune response in transgenic mice.

Judit Cervenak1, Balázs Bender, Zita Schneider, Melinda Magna, Bogdan Valer Carstea, Károly Liliom, Anna Erdei, Zsuzsanna Bosze, Imre Kacskovics.   

Abstract

The neonatal FcR (FcRn) regulates IgG and albumin homeostasis, mediates maternal IgG transport, takes active part in phagocytosis, and delivers Ag for presentation. We have previously shown that overexpression of FcRn in transgenic (Tg) mice extends the half-life of mouse IgG by reducing its clearance. In this paper, we demonstrate that immunization of these mice with OVA and trinitrophenyl-conjugated human IgG results in a 3- to 10-fold increase of Ag-specific IgM and IgG in serum. The IgM increase was unexpected because FcRn does not bind IgM. Our results showed that the affinity of the Ag-specific IgG was at least as good in Tg mice as in the wild-type (wt) controls, implying appropriate affinity maturation in both groups. Influenza vaccination produced a 2-fold increase in the amount of virus-specific Ab in Tg animals, which proved twice as efficient in a hemagglutination inhibition assay as was the case in wt controls. After immunization, Tg mice displayed significantly larger spleens containing a higher number of Ag-specific B cells and plasma cells, as well as many more granulocytes and dendritic cells, analyzed by ELISPOT and flow cytometric studies. The neutrophils from these Tg mice expressed the Tg FcRn and phagocytosed IgG immune complexes more efficiently than did those from wt mice. These results show that FcRn overexpression not only extends the IgG half-life but also enhances the expansion of Ag-specific B cells and plasma cells. Although both effects increase the level of Ag-specific IgG, the increase in immune response and IgG production seems to be more prominent compared with the reduced IgG clearance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148035     DOI: 10.4049/jimmunol.1000353

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Maternal antibody persistence: a neglected life-history trait with implications from albatross conservation to comparative immunology.

Authors:  R Garnier; R Ramos; V Staszewski; T Militão; E Lobato; J González-Solís; T Boulinier
Journal:  Proc Biol Sci       Date:  2011-12-21       Impact factor: 5.349

Review 2.  Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

Authors:  Imre Kacskovics; Judit Cervenak; Anna Erdei; Richard A Goldsby; John E Butler
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

3.  Knockout of the neonatal Fc receptor in cultured podocytes alters IL-6 signaling and the actin cytoskeleton.

Authors:  Pantipa Tonsawan; James Dylewski; Linda Lewis; Judith Blaine
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-25       Impact factor: 4.249

Review 4.  On the emerging role of rabbit as human disease model and the instrumental role of novel transgenic tools.

Authors:  V Duranthon; N Beaujean; M Brunner; K E Odening; A Navarrete Santos; I Kacskovics; L Hiripi; E J Weinstein; Z Bosze
Journal:  Transgenic Res       Date:  2012-03-02       Impact factor: 2.788

Review 5.  Using 2-photon microscopy to understand albuminuria.

Authors:  Bruce A Molitoris
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

Review 6.  The proximal tubule and albuminuria: really!

Authors:  Landon E Dickson; Mark C Wagner; Ruben M Sandoval; Bruce A Molitoris
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

7.  Functional polymorphisms in rhesus macaque FCGRT and β2-m.

Authors:  Zhanna Shubin; Yutaka Tagaya; Bhawna Poonia
Journal:  Immunogenetics       Date:  2017-08-07       Impact factor: 2.846

8.  FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen.

Authors:  Attila Végh; Judit Cervenak; István Jankovics; Imre Kacskovics
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

Review 9.  Neonatal Fc receptor and IgG-based therapeutics.

Authors:  Timothy T Kuo; Victoria G Aveson
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

Review 10.  Targeting FcRn for the modulation of antibody dynamics.

Authors:  E Sally Ward; Siva Charan Devanaboyina; Raimund J Ober
Journal:  Mol Immunol       Date:  2015-03-09       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.